文献速递肝病消化道肿瘤与早癌

含卷曲螺旋结构域50的剪接变异体受富含丝氨酸/精氨酸剪接因子3调控并通过Ras信号通路促进小鼠肝细胞癌

A Coiled-Coil Domain Containing 50 Splice Variant Is Modulated by Serine/Arginine-Rich Splicing Factor 3 and Promotes Hepatocellular Carcinoma in Mice by the Ras Signaling Pathway.
PubMed 文献 · Hepatology · 2018-12-22

研究揭示肝细胞癌中CCDC50前体mRNA异常剪接,产生截短的致癌剪接变异体CCDC50S;其mRNA在肝细胞癌中上调,具诊断潜力(敏感性0.711,特异性0.793),高表达与肿瘤低分化、晚期TNM分期及不良预后相关;机制上HBx/SRSF3/14-3-3β复合物调控CCDC50S稳定性,经Ras/Foxo4信号通路促进肝癌生长转移。

要点

  • CCDC50S mRNA在肝细胞癌中上调,诊断敏感性0.711、特异性0.793。
  • CCDC50S高表达与肿瘤低分化、晚期TNM分期及不良预后显著相关。
  • HBx/SRSF3/14-3-3β复合物调控CCDC50S,经Ras/Foxo4通路促进肝癌进展。

核心结论

  • CCDC50S上调由HBx/SRSF3/14-3-3β复合物调控,并通过Ras/Foxo4信号通路增强肝细胞癌的致癌进展。
  • CCDC50S可能作为肝细胞癌的诊断和预后生物标志物,并可能是潜在的治疗靶点。

研究设计与样本

  • 研究采用高通量测序发现50%的肝细胞癌病例中CCDC50前体mRNA异常剪接。
  • 采用BaseScope assay检测肝细胞癌组织中CCDC50S表达,并与良性肝肿瘤及其他几种实体瘤比较。

主要发现

  • 与良性肝肿瘤及其他几种实体瘤相比,CCDC50S mRNA在肝细胞癌中上调,诊断敏感性0.711、特异性0.793。
  • 肝细胞癌中CCDC50S mRNA高表达与肿瘤低分化、晚期TNM分期及不良预后显著相关。
  • CCDC50S过表达通过激活Ras/Foxo4信号通路发挥促癌活性,促进肝细胞癌生长和转移。
  • 抑制MEK/ERK磷酸化或过表达Foxo4可显著减弱CCDC50S介导的表型。
  • SRSF3直接结合CCDC50S mRNA以维持其在细胞质中的稳定性;SRSF3的胞质滞留由HBx与14-3-3β相互作用介导。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Deregulation of alternative splicing contributes to the malignant progression of cancer. Little is known about the significant alternative splicing events in hepatocellular carcinoma (HCC). High-throughput sequencing revealed that coiled-coil domain containing 50 (CCDC50) pre-mRNA is aberrantly spliced in 50% of our HCC cases. A BaseScope assay was performed to examine the expression of CCDC50S (a truncated oncogenic splice variant) in HCC tissues. Compared with benign liver tumors and several other types of solid tumors, CCDC50S mRNA was up-regulated in HCC, with a diagnostic potential (sensitivity, 0.711; specificity, 0.793). High expression of CCDC50S mRNA in HCC was significantly correlated with poor tumor differentiation, advanced tumor node metastasis (TNM) stage, and unfavorable prognosis. Overexpression of CCDC50S exerted tumorigenic activities that promoted HCC growth and metastasis by activation of Ras/forkhead box protein O4 (Foxo4) signaling. Either suppression of mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK) phosphorylation or overexpression of Foxo4 markedly attenuated CCDC50S-mediated phenotypes. Furthermore, serine- and arginine-rich splicing factor 3 (SRSF3) directly bound to CCDC50S mRNA to maintain its stability in the cytoplasm. The cytosolic retention of SRSF3 was mediated by the interaction of hepatitis B virus-encoded X protein (HBx) and 14-3-3β. Ectopic HBx expression induced expression of cytosolic SRSF3 and CCDC50S. Conclusion: Our study provided compelling evidence that up-regulation of CCDC50S was modulated by HBx/SRSF3/14-3-3β complex and enhanced oncogenic progression of HCC through the Ras/Foxo4 signaling pathway. These data suggest that CCDC50S may serve as a diagnostic and prognostic biomarker and probably a promising therapeutic target in HCC.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Wang H, Zhang CZ, Lu SX, et al. A Coiled-Coil Domain Containing 50 Splice Variant Is Modulated by Serine/Arginine-Rich Splicing Factor 3 and Promotes Hepatocellular Carcinoma in Mice by the Ras Signaling Pathway. Hepatology. 2018. PMID: 30028541. doi:10.1002/hep.30147

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。